AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)
AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)

Balance Sheet ACRS Quote Aclaris The

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 20142015201620172018
CashAndCashEqui 10 11 10 30 20
ShortTermInvest 4 5 75 107 174
Cash 13 16 85 0 0
AccountReceivab 0 0 0 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 13 16 87 139 200
PPE 0 1 0 1 3
AccumulatedDepr 0 0 0 0 0
NetPPE 0 1 0 0 2
EquityAndOtherI 1 1 7 37 15
Goodwill 0 0 0 0 19
IntangibleAsset 0 0 0 0 7
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 1 1 8 38 43
TotalAssets 14 17 94 176 244
ShortTermDebt 0 0 0 0 0
AccountsPayable 0 1 1 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 0 1 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 0 0 0 2 4
TotalCurrentLia 0 1 2 6 13
Debt 0 0 0 0 0
DeferredTaxesLi 0 0 0 0 1
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 23 37 0 0 5
TotalNonCurrent 23 37 0 0 5
TotalLiabilitie 23 38 2 7 18
CommonStock 0 0 0 0 0
AdditionalPaidI 0 0 136 261 385
RetainedEarning -9 -21 -43 -91 -159
AccumulatedOthe 0 0 0 0 0
TotalStockholde -9 -21 93 169 225
TotalLiabilitie 14 17 94 176 244
Aclaris Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Aclaris Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.